Debruyne, F. M., Behre, H. M., Roehrborn, C. G., Maggi, M., Wu, F. C., Schröder, F. H., Jones, T. H., Porst, H., Hackett, G., Wheaton, O. A., Martin‐Morales, A., Meuleman, E., Cunningham, G. R., Divan, H. A., Rosen, R. C., & , (2017). testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. BJU international, 119, 216–224. http://access.bl.uk/ark:/81055/vdc_100040722786.0x00001c